BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12867763)

  • 1. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
    Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.
    Dalmáz CA; Santos KG; Botton MR; Tedoldi CL; Roisenberg I
    Blood Cells Mol Dis; 2006; 37(2):107-10. PubMed ID: 16963292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia.
    Gerhardt A; Goecke TW; Beckmann MW; Wagner KJ; Tutschek B; Willers R; Bender HG; Scharf RE; Zotz RB
    J Thromb Haemost; 2005 Apr; 3(4):686-91. PubMed ID: 15842353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
    Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
    Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
    Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
    J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia.
    D'Elia AV; Driul L; Giacomello R; Colaone R; Fabbro D; Di Leonardo C; Florio P; Petraglia F; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2002; 53(2):84-7. PubMed ID: 11961379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study.
    Tempfer CB; Jirecek S; Riener EK; Zeisler H; Denschlag D; Hefler L; Husslein PW
    J Soc Gynecol Investig; 2004 May; 11(4):227-31. PubMed ID: 15120696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
    Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
    Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
    Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preeclampsia and its interaction with common variants in thrombophilia genes.
    De Maat MP; Jansen MW; Hille ET; Vos HL; Bloemenkamp KW; Buitendijk S; Helmerhorst FM; Wladimiroff JW; Bertina RM; De Groot CJ
    J Thromb Haemost; 2004 Sep; 2(9):1588-93. PubMed ID: 15333035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic hypofibrinolysis in complicated pregnancies.
    Glueck CJ; Kupferminc MJ; Fontaine RN; Wang P; Weksler BB; Eldor A
    Obstet Gynecol; 2001 Jan; 97(1):44-8. PubMed ID: 11152905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications.
    Donmez HG; Beksac MS
    Blood Coagul Fibrinolysis; 2023 Sep; 34(6):396-402. PubMed ID: 37577872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
    Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.